Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Osmolality Testing of Injectable Products – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Osmolality Testing of Injectable Products – V 2.0

Standard Operating Procedure for Osmolality Testing of Injectable Products


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/161/2025
Supersedes SOP/SIM/161/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

This SOP defines the method for determining osmolality of sterile injectable products using an osmometer. Osmolality testing ensures that injectable solutions are isotonic or appropriately adjusted for patient safety and comfort, particularly for intravenous, intramuscular, or ophthalmic preparations.

2. Scope

This SOP applies

to all injectable formulations manufactured at the facility that require osmolality testing as part of routine batch release, stability studies, or development trials.

3. Responsibilities

  • QC Analyst: Conduct osmolality tests and document the data.
  • QC Reviewer: Review raw data and compiled results for accuracy.
  • Instrument Technician: Calibrate and maintain the osmometer as per schedule.
  • QA Department: Review and approve final osmolality results.

4. Accountability

The Head of Quality Control is accountable for ensuring compliance with this SOP and for maintaining instrument readiness and data integrity.

See also  Manufacturing: SOP for Temperature and Humidity Monitoring during Production - V 2.0

5. Procedure

5.1 Principle

Osmolality is a measure of the osmotic concentration of a solution and is expressed in milliosmoles per kilogram of water (mOsm/kg H2O). The osmometer operates on the freezing point depression method, where the degree to which freezing point is lowered corresponds to the concentration of solute particles.

5.2 Equipment and Materials

  • Freezing point depression osmometer (e.g., Advanced Instruments Model 3250)
  • Micropipette with disposable tips
  • Calibrated thermometers
  • Calibration standards (100 mOsm/kg, 290 mOsm/kg, and 1000 mOsm/kg)
  • Deionized water
  • QC test sample
  • Log book or LIMS system

5.3 Calibration and Verification

  1. Calibrate the osmometer using certified osmolality standards before use.
  2. Document the calibration values in the calibration log (Annexure-1).
  3. Perform daily verification with 290 mOsm/kg control standard and record acceptance (±2% of label claim).

5.4 Sample Preparation

  1. Ensure the sample vial is labeled and traceable to the batch number.
  2. Equilibrate sample to room temperature (20–25°C).
  3. Mix the sample gently without introducing air bubbles.

5.5 Osmolality Measurement

  1. Turn on the osmometer and allow it to initialize.
  2. Use a micropipette to draw 50 μL of sample.
  3. Inject the sample into the sample port of the osmometer.
  4. Start the measurement cycle and allow instrument to complete freezing point depression analysis.
  5. Note the displayed osmolality reading (mOsm/kg) and document in test worksheet (Annexure-2).
  6. Repeat the analysis in duplicate to confirm reproducibility (±3 mOsm/kg).
See also  Sterile Injectable Manufacturing: SOP for Prefilled Syringe Filling Machine Operation - V 2.0

5.6 Acceptance Criteria

  • Osmolality of isotonic injectable products must fall within 270–310 mOsm/kg unless otherwise specified.
  • For hypertonic or hypotonic formulations, acceptance criteria should be defined in the product specification.
  • Difference between duplicate readings should not exceed 3 mOsm/kg.

5.7 Cleaning and Shutdown

  1. After use, flush the sample port with deionized water.
  2. Wipe external surfaces with lint-free cloth.
  3. Shut down the instrument and enter activity in instrument usage log.

5.8 Documentation

  1. All readings, observations, and calculations must be recorded in Annexure-2.
  2. Report deviations or out-of-specification results to QA using deviation form.
  3. Maintain raw data and logbooks for a minimum of 5 years or as per regulatory requirements.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • QA: Quality Assurance
  • LIMS: Laboratory Information Management System
  • mOsm/kg: Milliosmoles per kilogram of water
See also  Sterile Injectable Manufacturing: SOP for Sanitization of Airlocks in Sterile Manufacturing Facilities - V 2.0

7. Documents

  1. Calibration Log – Annexure-1
  2. Osmolality Test Worksheet – Annexure-2
  3. Instrument Usage Log – Annexure-3

8. References

  • USP <791> – Osmolality and Osmolarity
  • ICH Q2(R1) – Validation of Analytical Procedures
  • 21 CFR Part 211 – CGMP for Finished Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation QC Analyst QA Executive Head QA
Department Quality Control Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Calibration Log

Date Standard Used Expected Value Observed Value Performed By
24/06/2025 290 mOsm/kg 290 291 Arun Pillai

Annexure-2: Osmolality Test Worksheet

Sample ID Batch No. Test 1 Test 2 Average Status Analyst
INJ001 B230615 289 288 288.5 Pass Meena Iyer

Annexure-3: Instrument Usage Log

Date Time User Purpose Remarks
24/06/2025 10:00 AM Meena Iyer Batch Release Normal Operation

Revision History:

Revision Date Revision No. Details Reason Approved By
01/02/2022 1.0 Initial Version New SOP QA Head
24/06/2025 2.0 Added duplicate testing and annexures Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Filter Integrity Testing Lapses: A Critical GMP Compliance Concern
Next Post: LMS vs Paper-Based Training in SOP Compliance

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version